XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Collaboration agreements (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Collaboration agreements |
Schedule of Changes in the Balance of Our Contract Assets and Liabilities and Recognized Revenue | The following table presents changes in the balances of the Company's contract liabilities related to the GSK Agreement during the nine months ended September 30, 2022:
(in thousands) | Balance at Beginning of Period |  | Additions |  | Deductions |  | Balance at End of Period
Nine months ended September 30, 2022 |  |  |  |  |  |  |
Contract liabilities: |  |  |  |  |  |  |
Deferred revenue | $ | — |  |  | $ | 100,000 |  |  | $ | 655 |  |  | $ | 99,345 |
During the three and nine months ended September 30, 2022, the Company recognized the following revenues related to the GSK Agreement as a result of changes in the contract liability balances in the respective periods:
| Three Months Ended September 30, |  | Nine Months Ended September 30, |  |
(in thousands) | 2022 |  | 2022 |  |
Revenue recognized in the period from: |  |  |  |  |
Amounts included in the contract liability at the beginning of the period | $ | — |  |  | $ | — |  |  |
Performance obligations satisfied in previous periods | $ | — |  |  | $ | — |  |  |
The following table presents changes in the balances of the Company's contract liabilities related to the Janssen Agreement during the nine months ended September 30, 2022:
(in thousands) | Balance at Beginning of Period |  | Additions |  | Deductions |  | Balance at End of Period
Nine months ended September 30, 2022 |  |  |  |  |  |  |
Contract liabilities: |  |  |  |  |  |  |
Deferred revenue | $ | — |  |  | $ | 40,000 |  |  | $ | 10,916 |  |  | $ | 29,084 |
During the three and nine months ended September 30, 2022, the Company recognized the following revenues related to the Janssen Agreement as a result of changes in the contract liability balances in the respective periods:
| Three Months Ended September 30, |  | Nine Months Ended September 30, |  |
(in thousands) | 2022 |  | 2022 |  |
Revenue recognized in the period from: |  |  |  |  |
Amounts included in the contract liability at the beginning of the period | $ | 4,908 |  |  | $ | — |  |  |
Performance obligations satisfied in previous periods | $ | — |  |  | $ | — |  |  |
The following table presents changes in the balances of the Company's contract liabilities related to the Merck KGaA Agreement and Merck KGaA Supply Agreement during the nine months ended September 30, 2022 and 2021:
(in thousands) | Balance at Beginning of Period |  | Additions |  | Deductions |  | Balance at End of Period
Nine months ended September 30, 2022 |  |  |  |  |  |  |
Contract liabilities: |  |  |  |  |  |  |
Deferred revenue | $ | 3,944 |  |  | $ | — |  |  | $ | 32 |  |  | $ | 3,912 |
(in thousands) | Balance at Beginning of Period |  | Additions |  | Deductions |  | Balance at End of Period
Nine months ended September 30, 2021 |  |  |  |  |  |  |
Contract liabilities: |  |  |  |  |  |  |
Deferred revenue | $ | 3,987 |  |  | $ | — |  |  | $ | 32 |  |  | $ | 3,955 |
During the three and nine months ended September 30, 2022 and 2021, the Company recognized the following revenues related to the Merck KGaA Agreement and Merck KGaA Supply Agreement as a result of changes in the contract liability balances in the respective periods:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in thousands) | 2022 |  | 2021 |  | 2022 |  | 2021
Revenue recognized in the period from: |  |  |  |  |  |  |
Amounts included in the contract liability at the beginning of the period | $ | 11 |  |  | $ | 11 |  |  | $ | 32 |  |  | $ | 32 |
Performance obligations satisfied in previous periods | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |

X
- References No definition available. + Details
Name: | mrsn_CollaborationAgreementsAbstract
Namespace Prefix: | mrsn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration